The relation between cognition and motor dysfunction in drug-naive newly diagnosed patients with Parkinson's disease

Movement Disorders

Volumn 26, Issue 12, 2011, Pages 2183-2189

  Domellöf, Magdalena Eriksson ^a,b   Elgh, Eva ^b   Forsgren, Lars ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

Author keywords

Cognition; Newly diagnosed; Parkinson's disease; Population based

Indexed keywords

DOPAMINE; IOFLUPANE I 123;

ADULT; AGED; ARTICLE; BODY POSTURE; COGNITION; DEPTH PERCEPTION; DOPAMINERGIC SYSTEM; EDUCATIONAL STATUS; EPISODIC MEMORY; FEMALE; GAIT DISORDER; GROUPS BY AGE; HUMAN; MALE; MENTAL PERFORMANCE; MOTOR DYSFUNCTION; NEUROPSYCHOLOGY; PARKINSON DISEASE; PHENOTYPE; PRIORITY JOURNAL; SEX DIFFERENCE; WORKING MEMORY;

AGED; COGNITION DISORDERS; FEMALE; GAIT DISORDERS, NEUROLOGIC; HUMANS; HYPOKINESIA; MALE; MEMORY; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; REGRESSION ANALYSIS; SENSATION DISORDERS; SEVERITY OF ILLNESS INDEX; TREMOR;

EID: 80055073541     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23814     Document Type: Article

References (35)

1. Aarsland D, Bronnick K, Larsen JP, Tysnes OB, Alves G; Norwegian ParkWest Study. Cognitive impairment in incident, untreated Parkinson disease. Neurology 2009; 72: 1121-1126.
2. Muslimovic D, Post B, Speelman JD, Schmand B. Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology 2005; 65: 1239-1245.
3. Lewis SJG, Foltynie T, Blackwell AD, Robbins TW, Owen AM, Barker RA. Heterogeneity of Parkinson's disease in the early clinical stages using a data driven approach. J Neurol Neurosurg Psychiatry 2005; 76: 343-348.
4. Obeso JA, Rodriguez-Oroz MC, Goetz CG, et al. Missing pieces in the Parkinson's disease puzzle. Nat Med 2010; 16: 653-661.
5. Lewis SJG, Dove A, Robbins TW, Barker RA, Owen AM. Cognitive impairments in early Parkinson's disease are accompanied by reductions in activity in frontostriatal neural circuitry. J Neurosci 2003; 23: 6351-6356.
6. Marklund P, Larsson A, Elgh E, et al. Temporal dynamics of basal ganglia under-recruitment in Parkinson's disease: transient caudate abnormalities during updating of working memory. Brain 2009; 132: 336-346.
7. Lang A, Obeso J. Challenges in Parkinson's disease: restoration of the nigrostriatal dopamine system is not enough. Lancet Neurol 2004: 309-316.
8. Burn DJ, Rowan EN, Allan LM, Molloy S, T O'Brien J, McKeith IG. Motor subtype and cognitive decline in Parkinson's disease, Parkinson's disease with dementia, and dementia with Lewy bodies. J Neurol Neurosurg Psychiatry 2006; 77: 585-589.
9. Alves G, Larsen JP, Emre M, Wentzel-Larsen T, Aarsland D. Changes in motor subtype and risk for incident dementia in Parkinson's disease. Mov Disord 2006; 21: 1123-1130.
10. Lyros E, Messinis L, Papathanasopoulos P. Does motor subtype influence neurocognitive performance in Parkinson's disease without dementia? Eur J Neurology 2008; 15: 262-267.
11. Uc EY, McDermott MP, Marder KS, et al. Incidence of and risk factors for cognitive impairment in an early Parkinson disease clinical trial cohort. Neurology 2009; 73: 1469-1477.
12. Cools R. Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson's disease. Neurosci Biobehav Rev 2006; 30: 1-23.
13. Williams LN, Seignourel P, Crucian GP, et al. Laterality, region, and type of motor dysfunction correlate with cognitive impairment in Parkinson's disease. Mov Disord 2007; 22: 141-145.
14. Kieburtz K, Mcdermott M, Como P, et al. The effect of deprenyl and tocopherol on cognitive performance in early untreated Parkinson's disease. Neurology 1994; 44: 1756-1759.
15. Cooper JA, Sagar HJ, Jordan N, Harvey NS, Sullivan EV. Cognitive impairment in early, untreated Parkinson's disease and its relationship to motor disability. Brain 1991; 114: 2095-2122.
16. Elgh E, Domellof M, Linder J, Edstrom M, Stenlund H, Forsgren L. Cognitive function in early Parkinson's disease: a population-based study. Eur J Neurology 2009; 16: 1278-1284.
17. Linder J, Stenlund H, Forsgren L. Incidence of Parkinson's disease and parkinsonism in northern Sweden: a population-based study. Mov Disord 2010; 25: 341-348.
18. Gibb WRG, Lees AJ. A comparison of clinical and pathological features of young- and old-onset Parkinson's disease. Neurology 1988; 38: 1402-1406.
19. Fahn S. Recent Development in Parkinson's Disease. New York: Macmillan Health Care Information; 1987: 153-164.
20. Jankovic J, Mcdermott M, Carter J, et al. Variable Expression of Parkinson's disease-a base-line analysis of the DATATOP cohort. Neurology 1990; 40: 1529-1534.
21. Buschke H. Selective reminding analysis of memory and learning. J Verb Learn Verb Behav 1973; 12: 543-550.
22. Wechsler D. A Standardized memory scale for clinical use. J Psychol 1945; 19: 87-95.
23. Benedict R, Schretlen D, Groninger L, Dobraski M, Shpritz B. Revision of the Brief Visuospatial Memory Test: studies of normal performance, reliability, and validity. Psychol Assessment 1996; 8: 145-153.
24. Reitan R. Validity of the Trail Making Test as an indicator of organic brain damage. Percept Motor Skill 1958: 271-276.
25. Weschler D. Weschler Adult Intelligence Scale, 3rd edition (WAIS III): Test Manual. 3rd ed. New York: Psychological Corporation; 1997.
26. Kaplan E, Goodglass H, Weintraub S. Boston Naming Test. Philadelphia: Lea & Feiberg; 1983.
27. Spreen O, Strauss A. A Compendium of Neuropsychological Tests. 2nd ed. New York: Oxford University Press; 1998.
28. Benton A, Hamsher K, Varney N, Spreen O. Contributions to Neuropsychological Assessment. New York: Oxford University Press; 1983.
29. Heaton R. WCST: Computer version 2-research edition manual. Odessa, FL: Psychological Assessment Resources; 1993.
30. Vingerhoets FJG, Schulzer M, Caine DB, Snow BJ. Which clinical sign of Parkinson's disease best reflects the nigrostriatal lesion? Ann Neurol 1997; 41: 58-64.
31. Lewis SJG, Cools R, Robbins TW, Dove A, Barker RA, Owen AM. Using executive heterogeneity to explore the nature of working memory deficits in Parkinson's disease. Neuropsychologia 2003; 41: 645-654.
32. Obeso JA, Marin C, Rodriguez-Oroz C, et al. The basal ganglia in Parkinson's disease: current concepts and unexplained observations. Ann Neurol 2008; 64: S30-S46.
33. Bohnen NI, Muller MLTM, Koeppe RA, et al. History of falls in Parkinson disease is associated with reduced cholinergic activity. Neurology 2009; 73: 1670-1676.
34. Williams-Gray CH, Foltynie T, Brayne CEG, Robbins TW, Barker RA. Evolution of cognitive dysfunction in an incident Parkinson's disease cohort. Brain 2007; 130: 1787-1798.
35. Kehagia A, Barker R, Robbins T. Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease. Lancet Neurol 2010; 9: 1200-1213.